&nbsp;

DPM-HelpSection-14-connected.gif

Jan 2018

Regimen

DANAFARBER(INT-PEG)

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL)

Intent: Curative

Funding:

ODB - General Benefit

mercaptopurine

ODB - General Benefit

dexamethasone

New Drug Funding Program

Pegaspargase (Outpatient) - Adult Acute Lymphoblastic Leukemia (ALL) Lymphoblastic Lymphoma Mixed or Biphenotypic Leukemia

Drugs Used:

Quick Link(s):

Regimen Monograph

Dec 2021

Regimen

DDGP

Cancer Type:

Hematologic,

Lymphoma - T-cell

Intent: Curative

Funding:

New Drug Funding Program

Pegaspargase - Extranodal Natural Killer/T-cell Lymphoma

ODB - General Benefit

dexamethasone

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2022

Document

dapColorectalJuly18.xml

Jul 2018

Document

dapColorectalJuly18.html

Jul 2018

Document

dapLungJuly18.xml

Jul 2018

Document

dapLungJuly18.html

Jul 2018

Document

dapProstateJuly18.xml

Jul 2018

Document

dapProstateJuly18.html

Jul 2018

Regimen

DURV

Cancer Type:

Lung,

Non-Small Cell

Intent: Curative

Funding:

New Drug Funding Program

Durvalumab - Locally Advanced Unresectable Stage III Non-Small Cell Lung Cancer Following Concurrent Chemoradiation

Drugs Used:

durvalumab

... Show more tags

Quick Link(s):

Regimen Monograph

Jun 2024

Regimen

DENO

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Drugs Used:

denosumab (Unfunded)

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2024

Document